Disclosure Schedules Are a Structured Confession

Ahmed Hasan

Disclosure schedules are one of the most important parts of a deal and one of the most consistently misunderstood. Founders tend to treat them as an appendix. They’re actually where your reps get softened.

A structured confession

A typical rep says something like: the company has no material litigation, except as set forth in Schedule 3.5. Whatever you put on that schedule is, by definition, not a breach.

That makes the schedule a structured confession. A specific disclosure can defang a rep more effectively than a redline, because the buyer can’t bring an indemnity claim for something you disclosed. On deals with R&W insurance, known issues also fall outside the policy, so what you disclose shapes who ends up carrying which risk.

Three battlegrounds

Cross-application: Does a disclosure on Schedule 3.5, Litigation, also qualify rep 3.7, Compliance, and rep 3.12, Material Contracts? Buyers want section-specific application, where a litigation disclosure qualifies only the litigation rep. Sellers want any disclosure whose relevance to other reps is reasonably apparent on its face to qualify all of them. This single fight reshapes indemnity exposure across the entire agreement, and most founders never see it happen.

Bring-down updates: Schedules usually get updated between signing and closing, and the fight is whether an update cures a breach or merely discloses it. The answer decides whether new bad facts give the buyer a walk right or simply sit on the indemnity. In 2025, 54% of deals with a gap between signing and closing imposed an express duty on sellers to notify the buyer of pre-closing rep breaches; 46% were silent.

Process discipline: Drafting schedules is a 200-hour-plus exercise that founders consistently underestimate. Your CFO, your GC and outside counsel need to be in the data room two weeks before this work starts, not the day it does.

Treat it as negotiation

Every line on a schedule is a decision about risk. Draft them with the same care as the agreement itself, and settle the cross-application language before the schedules are written, not after.

Ahmed Hasan is the founder and CEO of Venture Bridge Law, a corporate and M&A boutique. This article is general information, not legal advice.

All articles in the series